Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 0.3853 Delayed Data As of 3:58pm ET |  -0.0013 / -0.34%Today’s Change | 0.38 Today|||52-Week Range 2.61 | -75.30% Year-to-Date |
Latest INO News | Press Releases
No recent news for Inovio Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.38 |
| Day’s range | 0.38 - 0.39 |
| Volume | 114,612 |
| Average volume (3 months) | 6,778,204 |
| Market cap | $114.7M |
Data as of 3:58pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +19.36% |
| Earnings growth (this year) | +51.28% |
| Earnings growth (next 5 years) | +41.52% |
| Revenue growth (last year) | +478.23% |
| P/E ratio | NM |
| Price/Sales | 36.27 |
| Price/Book | 0.49 |
Competitors
| ---- | ||
| ORMPOramed Pharmaceutica... | -0.05 | -1.90% |
| AQSTAquestive Therapeuti... | -0.06 | -3.68% |
| --W World Corp | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$279.8M |
| Net profit margin | -2,726.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
